Tempus AI posts first GAAP profit, boosts 2026 revenue forecast to $1.6B with FDA approval aiding growth
Tempus AI reported its first GAAP profit driven by growth in its data business and improved operating leverage from oncology volume and high-margin products. The company raised its 2026 revenue guidance to $1.595–$1.605 billion, a 25% increase year-o...
